General Information of MIC (ID: MIC00224)
MIC Name Bifidobacterium sp. (actinobacteria)
Body Site Gut
Lineage Kingdom: Bacteria
Phylum: Actinobacteria
Class: Actinobacteria
Order: Bifidobacteriales
Family: Bifidobacteriaceae
Genus: Bifidobacterium
Species: Bifidobacterium sp.
Oxygen Sensitivity Obligate anaerobe
Microbial Metabolism Saccharolytic; Fermentative
Gram Positive
Host Relationship Probiotic
Description Bifidobacterium is a genus of Gram-positive, nonmotile, often branched anaerobic bacteria. They are ubiquitous inhabitants of the gastrointestinal tract, vagina and mouth of mammals, including humans. Bifidobacteria are one of the major genera of bacteria that make up the gastrointestinal tract microbiota in mammals. Some bifidobacteria are used as probiotics.
External Links Taxonomy ID
41200
GOLD Organism ID
Go0541814
Disease Relevance
          Autism spectrum disorder  [ICD-11: 6A02]
             Description Bifidobacterium was reduced in children with autism spectrum disorder. [1]
          Behcet disease  [ICD-11: 4A62]
             Description The genus Bifidobacterium increased in relative abundance of gut microbiota in patients with Behcet's disease (BD). [2]
          Bipolar depression  [ICD-11: 6A60]
             Description Bifidobacteria was associated with bipolar depression . [3]
          Coeliac disease  [ICD-11: DA95]
             Description Bacterial counts of Bifidobacterium spp. decreased when the genetic risk of coeliac disease was increased. [4]
          Crohn disease  [ICD-11: DD70]
             Description Children with active and inactive Crohns disease had lower numbers of Bifidobacteria. [5]
          Inflammatory bowel disease  [ICD-11: DD72]
             Description Bifidobacteria is downregulated in disease expression of inflammatory bowel disease. [6]
          Irritable bowel syndrome  [ICD-11: DD91]
             Description These strains of Bifidobacterium sp. were being used as probiotics for the treatment of gastrointestinal tract infections and antibiotic-associated diarrhea. [7]
          Obesity  [ICD-11: 5B81]
             Description Children who became overweight by age 7 had lower levels of Bifidobacteria as infants compared with those that kept a healthy weight. [8]
          Providencia alcalifaciens gastroenteritis  [ICD-11: 1A40]
             Description Bifidobacteriumis one of the main genera of com-mensal bacteria present in the human GIT(gastrointestinal tract) and its pres-ence has been related to health benefits in severalstudies. [9]
          Retinal artery occlusions  [ICD-11: 9B74]
             Description Bifidobacterium spp. was relatively enriched in patients with retinal artery occlusion. [10]
          Schizophrenia  [ICD-11: 6A20]
             Description Bifidobacterium was relatively more abundant in schizophrenia which had been shown to modulate chronic inflammation. [11]
Host Genetic Factors (HGFs)
          VIPR2
             HGF ID HGF2350 HGF Info       Class Copy Number Variation: Gene Deletion (CNV-GDe)
             Description The deletion of VIPR2 has been associated with the increased abundance of Bifidobacterium sp. [12]
          MIR21
             HGF ID HGF2332 HGF Info       Class Copy Number Variation: Gene Deletion (CNV-GDe)
             Description The deletion of MIR-21 was significantly increased the proportion of Bifidobacterium (p-value<0.05). [13]
          TLR9
             HGF ID HGF2343 HGF Info       Class Copy Number Variation: Gene Deletion (CNV-GDe)
             Description The deletion of TLR9 decreased the amount of Bifidobacteria. [14]
          rs651821
             HGF ID HGF1924 HGF Info       Class Single Nucleotide Polymorphism: Prime UTR variant (SNP-PV)
             Description The APOA5 SNP rs651821 might be an important host genetic factor in determining the abundances of the health-promoting Bifidobacterium bacteria and the taxa to which this genus belongs. [15]
          rs9431487
             HGF ID HGF2283 HGF Info       Class Single Nucleotide Polymorphism (SNP)
             Description The rs9431487 SNP was significantly associated with the abundance of Bifidobacterium (p-value=5.71E-07). [16]
          rs892244
             HGF ID HGF2178 HGF Info       Class Single Nucleotide Polymorphism (SNP)
             Description The rs892244 SNP was significantly associated with the abundance of Bifidobacterium (p-value=1.23E-07). [16]
          rs8063330
             HGF ID HGF2179 HGF Info       Class Single Nucleotide Polymorphism (SNP)
             Description The rs8063330 SNP was significantly associated with the abundance of Bifidobacterium (p-value=2.28E-06). [16]
          rs8056064
             HGF ID HGF1867 HGF Info       Class Single Nucleotide Polymorphism: Intron variant (SNP-IV)
             Description The rs8056064 SNP was significantly associated with the abundance of Bifidobacterium (p-value=1.28E-05). [16]
          rs748841
             HGF ID HGF1688 HGF Info       Class Single Nucleotide Polymorphism: Intron variant (SNP-IV)
             Description The rs748841 SNP was significantly associated with the abundance of Bifidobacterium (p-value=1.84E-04). [17]
          rs6999452
             HGF ID HGF1237 HGF Info       Class Single Nucleotide Polymorphism: Intron variant (SNP-IV)
             Description The rs6999452 SNP was significantly associated with the abundance of Bifidobacterium (p-value=1.59E-05). [16]
          rs6683441
             HGF ID HGF2285 HGF Info       Class Single Nucleotide Polymorphism (SNP)
             Description The rs6683441 SNP was significantly associated with the abundance of Bifidobacterium (p-value=1.00E-06). [16]
          rs6541219
             HGF ID HGF2284 HGF Info       Class Single Nucleotide Polymorphism (SNP)
             Description The rs6541219 SNP was significantly associated with the abundance of Bifidobacterium (p-value=7.36E-07). [16]
          rs6469000
             HGF ID HGF1235 HGF Info       Class Single Nucleotide Polymorphism: Intron variant (SNP-IV)
             Description The rs6469000 SNP was significantly associated with the abundance of Bifidobacterium (p-value=3.06E-05). [16]
          rs4988235
             HGF ID HGF1523 HGF Info       Class Single Nucleotide Polymorphism: Intron variant (SNP-IV)
             Description The rs4988235 SNP was significantly associated with the abundance of Bifidobacterium (p-value<0.05). [18]
          rs4740829
             HGF ID HGF1694 HGF Info       Class Single Nucleotide Polymorphism: Non coding transcript variant (SNP-NCTV)
             Description The rs4740829 SNP was significantly associated with the abundance of Bifidobacterium (p-value=2.88E-06). [16]
          rs4734860
             HGF ID HGF1236 HGF Info       Class Single Nucleotide Polymorphism: Intron variant (SNP-IV)
             Description The rs4734860 SNP was significantly associated with the abundance of Bifidobacterium (p-value=3.06E-05). [16]
          rs4479964
             HGF ID HGF1920 HGF Info       Class Single Nucleotide Polymorphism: Intron variant (SNP-IV)
             Description The rs4479964 SNP was significantly associated with the abundance of Bifidobacterium (p-value=2.66E-05). [16]
          rs3754689
             HGF ID HGF1686 HGF Info       Class Single Nucleotide Polymorphism: Missense variant (SNP-MV)
             Description The rs3754689 SNP was associated with the abundance of Bifidobacterium (p-value=1.16E-05). [19]
          rs2304371
             HGF ID HGF1687 HGF Info       Class Single Nucleotide Polymorphism: Missense variant (SNP-MV)
             Description The rs2304371 SNP was associated with the abundance of Bifidobacterium (p-value=4.14E-06). [19]
          rs1446585
             HGF ID HGF1397 HGF Info       Class Single Nucleotide Polymorphism: Missense variant (SNP-MV)
             Description The rs1446585 SNP was significantly associated with the abundance of Bifidobacterium (p-value=3.89E-08). [18]
          rs1050115
             HGF ID HGF1248 HGF Info       Class Single Nucleotide Polymorphism: Synonymous variant (SNP-SV)
             Description The rs1050115 SNP was associated with the abundance of Bifidobacterium (p-value=6.51E-06). [19]
          rs6740462
             HGF ID HGF2537 HGF Info       Class Single Nucleotide Polymorphism: Intron variant (SNP-IV)
             Description The rs6740462 SNP is associated with the abundance of Bifidobacterium. [20]
          rs2816958
             HGF ID HGF2538 HGF Info       Class Single Nucleotide Polymorphism: Intron variant (SNP-IV)
             Description The rs2816958 SNP is associated with the abundance of Bifidobacterium. [20]
          rs1363907
             HGF ID HGF2539 HGF Info       Class Single Nucleotide Polymorphism: Intron variant (SNP-IV)
             Description The rs1363907 SNP is associated with the abundance of Bifidobacterium. [20]
          rs2457996
             HGF ID HGF2540 HGF Info       Class Single Nucleotide Polymorphism (SNP)
             Description The rs2457996 SNP is associated with the abundance of Bifidobacterium. [20]
          rs12994997
             HGF ID HGF2541 HGF Info       Class Single Nucleotide Polymorphism: Intron variant (SNP-IV)
             Description The rs12994997 SNP is associated with the abundance of Bifidobacterium. [20]
          rs7404095
             HGF ID HGF2542 HGF Info       Class Single Nucleotide Polymorphism: Intron variant (SNP-IV)
             Description The rs7404095 SNP is associated with the abundance of Bifidobacterium. [20]
          rs10486483
             HGF ID HGF2543 HGF Info       Class Single Nucleotide Polymorphism: Intron variant (SNP-IV)
             Description The rs10486483 SNP is associated with the abundance of Bifidobacterium. [20]
          rs6708413
             HGF ID HGF2544 HGF Info       Class Single Nucleotide Polymorphism: Intron variant (SNP-IV)
             Description The rs6708413 SNP is associated with the abundance of Bifidobacterium. [20]
          rs4728142
             HGF ID HGF2545 HGF Info       Class Single Nucleotide Polymorphism (SNP)
             Description The rs4728142 SNP is associated with the abundance of Bifidobacterium. [20]
          rs2111485
             HGF ID HGF2546 HGF Info       Class Single Nucleotide Polymorphism (SNP)
             Description The rs2111485 SNP is associated with the abundance of Bifidobacterium. [20]
          rs1517352
             HGF ID HGF2547 HGF Info       Class Single Nucleotide Polymorphism (SNP)
             Description The rs1517352 SNP is associated with the abundance of Bifidobacterium. [20]
          rs2823286
             HGF ID HGF2548 HGF Info       Class Single Nucleotide Polymorphism: Intron variant (SNP-UV)
             Description The rs2823286 SNP is associated with the abundance of Bifidobacterium. [20]
          rs6920220
             HGF ID HGF2532 HGF Info       Class Single Nucleotide Polymorphism (SNP)
             Description The rs6920220 SNP is associated with the abundance of Bifidobacterium. [20]
Host Immune Factors (HIFs)
          C-C motif chemokine 17
             HIF ID HIFM0019 HIF Info       Class Antimicrobial peptide (AMP)
             Description Bifidobacterium species strains decreased CCL17 secretion without affecting cell viability. [21]
          Polypeptide YY
             HIF ID HIFM0194 HIF Info       Class Antimicrobial peptide (AMP)
             Description The short chain fatty acids (SCFAs), produced in anaerobe conditions by Bifidobacteria, triggered polypeptide YY release by gut mucosal cells. [22]
          Regenerating islet-derived protein 3-gamma
             HIF ID HIFM0198 HIF Info       Class Antimicrobial peptide (AMP)
             Description The increasing probiotic Bifidobacteria can restore the properties of RegIII gamma. [23]
          CD20+ B cells
             HIF ID HIFC0137 HIF Info       Class B cells (BCs)
             Description Bifidobacterium was negatively correlated with CD20+ B cell counts in the portal tract in patients with simple steatosis. [24]
          B- and T-lymphocyte attenuator
             HIF ID HIFM0009 HIF Info       Class Checkpoint molecule (CM)
             Description The continuous high expression of BTLA on CD4+ T cells in bifidobacterium therapy group. [25]
          Tumor necrosis factor receptor superfamily member 7
             HIF ID HIFM0044 HIF Info       Class Checkpoint molecule (CM)
             Description The abundance of Bifidobacteria was associated with higher numbers of CD20(+) B cells that expressed the memory marker CD27 at 4 and 18 mo of age. [26]
          Antigenic surface determinant protein OA3
             HIF ID HIFM0052 HIF Info       Class Checkpoint molecule (CM)
             Description Local delivery of Bifidobacterium potently stimulates STING signaling and increases cross-priming of dendritic cells after anti-CD47 treatment. [27]
          Programmed death-ligand 1
             HIF ID HIFM0189 HIF Info       Class Checkpoint molecule (CM)
             Description Bifidobacterium have been associated with response to PD-L1 blockade in humans. [28]
          Tumor necrosis factor receptor superfamily member 9
             HIF ID HIFM0233 HIF Info       Class Checkpoint molecule (CM)
             Description The abundance of Bifidobacteria is associated with 4-1BB. [29]
          C-C motif chemokine 11
             HIF ID HIFM0017 HIF Info       Class Cytokine (Cyt)
             Description Oral administration of Bifidobacterium blocked pro-inflammatory cytokines CCL11 expression in the gut. [30]
          Class IIhi dendritic cells
             HIF ID HIFC0162 HIF Info       Class Dendritic cells (DCs)
             Description The levels of major histocompatibility complex (MHC) Class IIhi DCs increased in the tumors of Bifidobacterium-treated subjects. [31]
          Bone marrow-derived dendritic cells
             HIF ID HIFC0166 HIF Info       Class Dendritic cells (DCs)
             Description Bifidobacteria is able to induce autophagy activation in bone marrow-derived dendritic cells. [32]
          Immunoglobulin A
             HIF ID HIFM0272 HIF Info       Class Immunoglobulin (Ig)
             Description Levels of IgA correlated with relative abundances of operational taxonomic units (OTUs) belonging to the Bifidobacteria. [33]
          Immunoglobulin A1
             HIF ID HIFM0275 HIF Info       Class Immunoglobulin (Ig)
             Description Bifidobacterium was coated by IgA1. [34]
          Immunoglobulin A2
             HIF ID HIFM0276 HIF Info       Class Immunoglobulin (Ig)
             Description Bifidobacterium was coated by IgA2. [34]
          Immunoglobulin M
             HIF ID HIFM0266 HIF Info       Class Immunoglobulin (Ig)
             Description IgM coated Bifidobacteria. [33]
          Kupffer macrophages
             HIF ID HIFC0169 HIF Info       Class Macrophages (Mac)
             Description Bifidobacterium can cause significant Kupffer cells hyperplasia. [35]
          THP-1 monocytes
             HIF ID HIFC0214 HIF Info       Class Monocytes (Mono)
             Description Human intestinal mucosa-associated Bifidobacterium strains with probiotic properties modulated gene expression in THP-1 cells. [36]
          CD14+ CD16+ monocytes
             HIF ID HIFC0209 HIF Info       Class Monocytes (Mono)
             Description The increase in numbers of Bifidobacterium was negatively correlated with CCR2 and CX3CR1 expressions on CD14+CD16+ monocytes. [37]
          Helios IL10+FOXP3+CD4+ regulatory T cells
             HIF ID HIFC0189 HIF Info       Class T cells (TCs)
             Description Bifidobacteria is related to the proliferation, enhanced suppressive capacity and homing of HeliosIL10+FOXP3+CD4+ Treg cells in the colon. [38]
Environmental Factor(s)
             Disbiome ID
      43
             gutMDisorder ID
      gm0114
References
1 Differences in fecal microbial metabolites and microbiota of children with autism spectrum disorders. Anaerobe. 2018 Feb;49:121-131. doi: 10.1016/j.anaerobe.2017.12.007. Epub 2017 Dec 22.
2 Relative abundance of Megamonas hypermegale and Butyrivibrio species decreased in the intestine and its possible association with the T cell aberration by metabolite alteration in patients with Behcet's disease (210 characters). Clin Rheumatol. 2019 May;38(5):1437-1445. doi: 10.1007/s10067-018-04419-8. Epub 2019 Jan 9.
3 Gut Microbiota in Bipolar Depression and Its Relationship to Brain Function: An Advanced Exploration. Front Psychiatry. 2019 Oct 29;10:784. doi: 10.3389/fpsyt.2019.00784. eCollection 2019.
4 Influence of milk-feeding type and genetic risk of developing coeliac disease on intestinal microbiota of infants: the PROFICEL study. PLoS One. 2012;7(2):e30791. doi: 10.1371/journal.pone.0030791. Epub 2012 Feb 3.
5 Microbiota in pediatric inflammatory bowel disease. J Pediatr. 2010 Aug;157(2):240-244.e1. doi: 10.1016/j.jpeds.2010.02.046. Epub 2010 Apr 18.
6 Dysbiosis in the pathogenesis of pediatric inflammatory bowel diseases. Int J Inflam. 2012;2012:687143. doi: 10.1155/2012/687143. Epub 2012 May 20.
7 Bifidobacterium: An Emerging Clinically Significant Metronidazole-resistant Anaerobe of Mixed Pyogenic Infections.Cureus. 2017 Apr 4;9(4):e1134. doi: 10.7759/cureus.1134.
8 Obesity and the human microbiome. Curr Opin Gastroenterol. 2010 Jan;26(1):5-11. doi: 10.1097/MOG.0b013e328333d751.
9 Bifidobacteria and Their Health-Promoting Effects. Microbiol Spectr. 2017 Jun;5(3). doi: 10.1128/microbiolspec.BAD-0010-2016.
10 Retinal artery occlusion is associated with compositional and functional shifts in the gut microbiome and altered trimethylamine-N-oxide levels. Sci Rep. 2019 Oct 25;9(1):15303. doi: 10.1038/s41598-019-51698-5.
11 Composition, taxonomy and functional diversity of the oropharynx microbiome in individuals with schizophrenia and controls. PeerJ. 2015 Aug 25;3:e1140. doi: 10.7717/peerj.1140. eCollection 2015.
12 Association of gut microbiota composition and copy number variation with Kasai procedure outcomes in infants with biliary atresia.Pediatr Neonatol. 2020 Apr;61(2):238-240. doi: 10.1016/j.pedneo.2019.12.011. Epub 2020 Jan 7.
13 Loss of MicroRNA-21 Influences the Gut Microbiota, Causing Reduced Susceptibility in a Murine Model of Colitis.J Crohns Colitis. 2018 Jun 28;12(7):835-848. doi: 10.1093/ecco-jcc/jjy038.
14 Current understanding of the gut microbiota shaping mechanisms.J Biomed Sci. 2019 Aug 21;26(1):59. doi: 10.1186/s12929-019-0554-5.
15 The effect of heritability and host genetics on the gut microbiota and metabolic syndrome.Gut. 2017 Jun;66(6):1031-1038. doi: 10.1136/gutjnl-2015-311326. Epub 2016 Apr 6.
16 Genome-Wide Association Studies of the Human Gut Microbiota.PLoS One. 2015 Nov 3;10(11):e0140301. doi: 10.1371/journal.pone.0140301. eCollection 2015.
17 Whole exome sequencing analyses reveal gene-microbiota interactions in the context of IBD.Gut. 2020 Jul 10:gutjnl-2019-319706. doi: 10.1136/gutjnl-2019-319706. Online ahead of print.
18 Genetic Determinants of the Gut Microbiome in UK Twins.Cell Host Microbe. 2016 May 11;19(5):731-43. doi: 10.1016/j.chom.2016.04.017.
19 Host genetic variation impacts microbiome composition across human body sites.Genome Biol. 2015 Sep 15;16(1):191. doi: 10.1186/s13059-015-0759-1.
20 A Microbe Associated with Sleep Revealed by a Novel Systems Genetic Analysis of the Microbiome in Collaborative Cross Mice. Genetics. 2020 Mar;214(3):719-733. doi: 10.1534/genetics.119.303013. Epub 2020 Jan 2.
21 D-tryptophan from probiotic bacteria influences the gut microbiome and allergic airway disease.J Allergy Clin Immunol. 2017 May;139(5):1525-1535. doi: 10.1016/j.jaci.2016.09.003. Epub 2016 Sep 23.
22 Targeting patients' microbiota with probiotics and natural fibers in adults and children with constipation.Eur Rev Med Pharmacol Sci. 2018 Oct;22(20):7045-7057. doi: 10.26355/eurrev_201810_16177.
23 Leaky Gut As a Danger Signal for Autoimmune Diseases.Front Immunol. 2017 May 23;8:598. doi: 10.3389/fimmu.2017.00598. eCollection 2017.
24 Markers of activated inflammatory cells are associated with disease severity and intestinal microbiota inadults with nonalcoholic fatty liver disease.Int J Mol Med. 2018 Oct;42(4):2229-2237. doi: 10.3892/ijmm.2018.3800. Epub 2018 Aug 2.
25 Effects of clostridium butyricum and bifidobacterium on BTLA expression on CD4(+) T cells and lymphocyte differentiation in late preterm infants.Microb Pathog. 2016 Nov;100:112-118. doi: 10.1016/j.micpath.2016.09.008. Epub 2016 Sep 10.
26 Infant B cell memory differentiation and early gut bacterial colonization.J Immunol. 2012 May 1;188(9):4315-22. doi: 10.4049/jimmunol.1103223. Epub 2012 Apr 4.
27 Intratumoral accumulation of gut microbiota facilitates CD47-based immunotherapy via STING signaling.J Exp Med. 2020 May 4;217(5):e20192282. doi: 10.1084/jem.20192282.
28 The gut microbiome and response to immune checkpoint inhibitors: preclinical and clinical strategies.Clin Transl Med. 2019 Mar 18;8(1):9. doi: 10.1186/s40169-019-0225-x.
29 Microbiome Dependent Regulation of T(regs) and Th17 Cells in Mucosa.Front Immunol. 2019 Mar 8;10:426. doi: 10.3389/fimmu.2019.00426. eCollection 2019.
30 Not Avaliable
31 Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy.Science. 2015 Nov 27;350(6264):1084-9. doi: 10.1126/science.aac4255. Epub 2015 Nov 5.
32 Autophagy: A Novel Mechanism Involved in the Anti-Inflammatory Abilities of Probiotics.Cell Physiol Biochem. 2019;53(5):774-793. doi: 10.33594/000000172.
33 Interactions between the Gut Microbiome and Mucosal Immunoglobulins A, M, and G in the Developing Infant Gut.mSystems. 2019 Nov 26;4(6):e00612-19. doi: 10.1128/mSystems.00612-19.
34 Human IgA binds a diverse array of commensal bacteria.J Exp Med. 2020 Mar 2;217(3):e20181635. doi: 10.1084/jem.20181635.
35 Fecal Microbiota of Diarrhea-Predominant Irritable Bowel Syndrome Patients Causes Hepatic Inflammation of Germ-Free Rats and Berberine Reverses It Partially.Biomed Res Int. 2019 Apr 3;2019:4530203. doi: 10.1155/2019/4530203. eCollection 2019.
36 Human intestinal mucosa-associated Lactobacillus and Bifidobacterium strains with probiotic properties modulate IL-10, IL-6 and IL-12 gene expression in THP-1 cells. Benef Microbes. 2015;6(3):325-36. doi: 10.3920/BM2014.0081.
37 Change in gut microbiota is correlated with alterations in the surface molecule expression of monocytes after Roux-en-Y gastric bypass surgery in obese type 2 diabetic patients. Am J Transl Res. 2017 Mar 15;9(3):1243-1254. eCollection 2017.
38 Development and maintenance of intestinal regulatory T cells.Nat Rev Immunol. 2016 May;16(5):295-309. doi: 10.1038/nri.2016.36. Epub 2016 Apr 18.

If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.